7.4 Improvements in Individual Disease Components Are Sustained With Long-Term Adalimumab Therapy for Polyarticular Juvenile Idiopathic Arthritis

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-6-s1-s14